Official Site of The State of New JerseyOfficial Site of The State of New JerseyThe State of NJ site may contain optional links, information, services and/or content from other websites operated by third parties that are provided as a convenience, such as Google™ Translate. Google™ Translate is an online service for which the user pays nothing to obtain a purported language translation. The user is on notice that neither the State of NJ site nor its operators review any of the services, information and/or content from anything that may be linked to the State of NJ site for any reason. -Read Full Disclaimer close
The Jake Honig Compassionate Use Medical Cannabis Act provides the framework for the medicinal use of cannabis in New Jersey. The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization (CREAMM) Act does the same for recreational use and includes the establishment of the Cannabis Regulatory Commission. The Personal-Use Cannabis Rules (N.J.A.C 17:30) were last updated/amended effective March 6, 2023 (Cannabis rules may be found in Title 17, chapters 30 and 30A.) Highlights of the new rules are available here.
Link to submit public comments
October 16, 2023
Adult-Use Cannabis Rules
The Commission is proposing to add new rules allowing additional ingestible forms of cannabis.
Key components of the proposed edible rules will enhance variety, safety, and quality of edible products. The rules expand to include ingredients the Food and Drug Administration (FDA) generally regards as safe but prohibits the inclusion of harmful substances. In addition, ingestible products will only include shelf-stable, ready to use items that cannot require cooking, baking, or storage in sterile environments.
Adult-Use Cannabis Rules
Proposed amendments regarding Clinical Registrants: N.J.A.C. 17:30A-1.2 and 7.1
The proposed rules pertain to the permitting and operation of clinical registrants, which are clinically focused alternative treatment centers. Clinical registrants must be partnered with an academic medical center in the region to conduct research on medicinal cannabis and its applications - in addition to cultivating, manufacturing, and dispensing medicinal cannabis and medicinal cannabis products to qualifying patients and designated and institutional caregivers.
The public comment period was closed on Friday, October 6, 2023.
Adoption - Comments & Responses here.
January 17, 2023
Adult-Use Cannabis Rules
NJ-CRC Rules with proposed amendments regarding cannabis consumption areas: N.J.A.C. 17:30
The public comment period was closed on Saturday, March 18, 2023.
Adoption - Comments & Responses here.
Adult-Use Cannabis Rules
Proposed Readoption of Specially Adopted New Rules with Amendments: N.J.A.C. 17:30
The public comment period was closed on Friday, September 30, 2022.
Adoption - Comments & Responses here.
Note: LexisNexis provides free online public access to the New Jersey Adminstrative Code and the New Jersey Register.
The CRC was created to establish rules and regulations governing the sale and purchase of recreational cannabis, to administer the state’s medicinal cannabis program, and to oversee licensing for all areas of the cannabis industry.
Municipalities determine their own regulations and zoning ordinances governing the number, type, and operations of cannabis businesses within their borders. The CRC will not issue a license that would be in violation of a local ordinance or regulation.
Contact your municipality to verify local regulations.
The following are the laws, regulations, and guidelines that define and govern the Medicinal Marijuana Program in New Jersey.
COVID-19 Waivers and Guidance
*Page hosted by Lexis-Nexis
The Controlled Substances Act, 21 U.S.C. §§ 801 et seq., prohibits the cultivation, distribution, and possession of marijuana, for any reason, regardless of state law. New Jersey’s cannabis regulations conflict with Federal law, however “States are not required to enforce [Federal] law or prosecute people for engaging in activities prohibited by [Federal] law; therefore, compliance with [the Act] does not put the State of New Jersey in violation of [Federal] law,” and N.J.S.A. 24:6I-54 further directs law enforcement in New Jersey to not cooperate with federal agencies enforcing The Controlled Substances Act for activities solely authorized by the Act.
United States Attorneys are instructed to focus on the following eight enforcement interests in prioritizing the prosecution of Federal laws criminalizing marijuana-related activity:
